UY32879A - Tratamiento con fampridina de liberación sostenida en pacientes con esclerosis multiple - Google Patents
Tratamiento con fampridina de liberación sostenida en pacientes con esclerosis multipleInfo
- Publication number
- UY32879A UY32879A UY0001032879A UY32879A UY32879A UY 32879 A UY32879 A UY 32879A UY 0001032879 A UY0001032879 A UY 0001032879A UY 32879 A UY32879 A UY 32879A UY 32879 A UY32879 A UY 32879A
- Authority
- UY
- Uruguay
- Prior art keywords
- patients
- treatment
- sustained release
- multiple sclerosis
- release fampridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Abstract
Se describen en el presente métodos y composiciones relacionados con el uso de aminopiridinas, como ser la fampiridina, para mejorar las lesiones en pacientes con trastornos de la desmielinización, como ser la EM.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24010009P | 2009-09-04 | 2009-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32879A true UY32879A (es) | 2011-03-31 |
Family
ID=43649681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032879A UY32879A (es) | 2009-09-04 | 2010-09-06 | Tratamiento con fampridina de liberación sostenida en pacientes con esclerosis multiple |
Country Status (11)
Country | Link |
---|---|
US (8) | US20130267566A1 (es) |
EP (2) | EP2473039A4 (es) |
KR (2) | KR20170120708A (es) |
CN (1) | CN102143686A (es) |
AR (1) | AR078323A1 (es) |
BR (1) | BRPI1003988A2 (es) |
IL (1) | IL214560A0 (es) |
MY (1) | MY174829A (es) |
TW (1) | TW201125562A (es) |
UY (1) | UY32879A (es) |
WO (1) | WO2011029082A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8007826B2 (en) | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
US8354437B2 (en) | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
CA2911307C (en) | 2012-05-17 | 2021-05-25 | The University Of Chicago | Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging |
US9617215B2 (en) | 2012-05-17 | 2017-04-11 | The University Of Chicago | Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging |
RU2686116C1 (ru) * | 2018-06-27 | 2019-04-24 | Общество С Ограниченной Ответственностью "Инновационные Фармакологические Разработки" (Ооо "Ифар") | Способ количественного определения 4-амино-1-(3-нитро-2-оксо-1-фенил-1,2-дигидро-1,6-нафтиридин-5-ил)пиридиний хлорида в биологических средах |
WO2021201966A1 (en) | 2020-04-02 | 2021-10-07 | Massachusetts Institute Of Technology | A chip-scale optical coherence tomography engine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1082804A (en) | 1912-11-19 | 1913-12-30 | Gerald G Griffin | Confetti-machine. |
US8007826B2 (en) * | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
US8354437B2 (en) * | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
US7884079B2 (en) * | 2004-12-27 | 2011-02-08 | Miller Landon C G | 4-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders |
KR20170034452A (ko) * | 2009-02-11 | 2017-03-28 | 아코르다 쎄라퓨틱스 인코포레이티드 | 아미노피리딘을 사용한 연장 요법을 위한 조성물 및 방법 |
-
2010
- 2010-09-03 AR ARP100103241A patent/AR078323A1/es unknown
- 2010-09-03 TW TW099130003A patent/TW201125562A/zh unknown
- 2010-09-06 EP EP10814616A patent/EP2473039A4/en not_active Ceased
- 2010-09-06 MY MYPI2011003986A patent/MY174829A/en unknown
- 2010-09-06 UY UY0001032879A patent/UY32879A/es not_active Application Discontinuation
- 2010-09-06 WO PCT/US2010/047932 patent/WO2011029082A1/en active Application Filing
- 2010-09-06 CN CN2010800023728A patent/CN102143686A/zh active Pending
- 2010-09-06 KR KR1020177029828A patent/KR20170120708A/ko not_active Application Discontinuation
- 2010-09-06 KR KR1020127008634A patent/KR20120050512A/ko active Application Filing
- 2010-09-06 BR BRPI1003988-0A patent/BRPI1003988A2/pt not_active IP Right Cessation
- 2010-09-06 EP EP17152965.4A patent/EP3210606A1/en not_active Withdrawn
- 2010-09-06 US US13/394,044 patent/US20130267566A1/en not_active Abandoned
-
2011
- 2011-08-09 IL IL214560A patent/IL214560A0/en unknown
-
2014
- 2014-03-21 US US14/222,535 patent/US20140206728A1/en not_active Abandoned
-
2016
- 2016-03-08 US US15/064,574 patent/US20160184286A1/en not_active Abandoned
- 2016-10-21 US US15/331,713 patent/US20170035742A1/en not_active Abandoned
-
2017
- 2017-06-02 US US15/612,925 patent/US20170266171A1/en not_active Abandoned
-
2018
- 2018-09-06 US US16/124,045 patent/US20190000820A1/en not_active Abandoned
-
2019
- 2019-04-24 US US16/393,586 patent/US20190247378A1/en not_active Abandoned
- 2019-12-06 US US16/706,573 patent/US20200113883A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MY174829A (en) | 2020-05-18 |
US20190000820A1 (en) | 2019-01-03 |
US20170266171A1 (en) | 2017-09-21 |
BRPI1003988A2 (pt) | 2015-08-25 |
TW201125562A (en) | 2011-08-01 |
AR078323A1 (es) | 2011-11-02 |
EP2473039A1 (en) | 2012-07-11 |
WO2011029082A1 (en) | 2011-03-10 |
KR20170120708A (ko) | 2017-10-31 |
US20130267566A1 (en) | 2013-10-10 |
US20160184286A1 (en) | 2016-06-30 |
IL214560A0 (en) | 2011-09-27 |
EP3210606A1 (en) | 2017-08-30 |
US20190247378A1 (en) | 2019-08-15 |
WO2011029082A8 (en) | 2011-05-12 |
US20170035742A1 (en) | 2017-02-09 |
US20140206728A1 (en) | 2014-07-24 |
KR20120050512A (ko) | 2012-05-18 |
US20200113883A1 (en) | 2020-04-16 |
CN102143686A (zh) | 2011-08-03 |
EP2473039A4 (en) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018236800B2 (en) | DNA-PK inhibitors | |
CU20140141A7 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas | |
NI201100155A (es) | Composiciones y métodos para el tratamiento prolongado con aminopiridinas | |
BR112015029386A2 (pt) | uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer | |
AR089993A1 (es) | Macrociclos peptidomimeticos | |
CU23874B1 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
DOP2013000036A (es) | Derivados de ciclobutano como inhibidores de jak | |
GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
UY34278A (es) | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades | |
CL2012003604A1 (es) | Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros. | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
AR090339A1 (es) | Metodos de pronostico, diagnostico y tratamiento de la fibrosis pulmonar idiopatica | |
CO6440524A2 (es) | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la quinasa janus. | |
CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
CR11818A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
UY32879A (es) | Tratamiento con fampridina de liberación sostenida en pacientes con esclerosis multiple | |
CL2014003325A1 (es) | Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer | |
DOP2009000285A (es) | (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulacion sanguinea. | |
NI201300100A (es) | Derivados de tieno [2, 3-d] pirimidina y su uso para tratar arritmias | |
CO7151515A2 (es) | Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina | |
TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. | |
CL2011002626A1 (es) | Compuestos derivados de piperazina, como antagonistas del receptor p2y12; composicion farmaceutica que los contienen; y su uso en el tratamiento de trastornos vasculares oclusivos. | |
ECSP11011535A (es) | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la quinasa janus | |
TR201904627T4 (tr) | Hedefe yönelik termomodülasyona yönelik bileşimler ve yöntemler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
104 | Application deemed to be withdrawn (no substantive examination fee paid) |
Effective date: 20130806 |